Surgery Partners, Inc. (SGRY) Stock Score, Valuation & Financial Research
Surgery Partners, Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 20/100.
Quick answer for SGRY
Surgery Partners, Inc. currently has a Wall Street Score of 20/100. The stored market price is $13.65. Its financial score is 21/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Surgery Partners, Inc. does
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical faciliti
SGRY financial snapshot
- Wall Street Score:
- 20/100
- Current price:
- $13.65
- Market capitalization:
- $1.79B
- Revenue:
- $3.34B
- Net income:
- $-76.1M
- Free cash flow:
- $195.6M
- Cash:
- $182.3M
- Total debt:
- $4.03B
- EPS:
- -0.61
- Financial score:
- 21/100
- Valuation score:
- 0/100
- Revenue score:
- 26/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $195.6M, showing positive cash generation.
- The balance sheet shows $182.3M of cash versus $4.03B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 21/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SGRY
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.